Qingdao Haier Biomedical Co., Ltd.SSE: 688139

Announcement on Conducting Foreign Exchange Hedging Business

Mar 29, 2025 · Issued by Qingdao Haier Biomedical Co., Ltd. via Shanghai Stock Exchange

Filed with SSE · Mar 29, 2025

On 6ix: 6ix.com/news/announcement-on-conducting-foreign-exchange-hedging-business-23

Announcement on Conducting Foreign Exchange Hedging Business

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

6ix hasn’t read this filing yet.

Qingdao Haier Biomedical Co., Ltd. on 6ix

Earlier from Qingdao Haier Biomedical

Announcement on Preliminary Earnings Estimate for 2024Feb 28, 2025
Indicative Announcement on Shareholding Increase by Persons Acting in Concert of Actual Controllers Reaching 1%Feb 26, 2025
Announcement on Initially Repurchasing Shares Through Call AuctionJan 23, 2025
Announcement on Shareholdings of Top 10 Shareholders and Top 10 Holders of Shares Without Sales Restrictions Concerning Share RepurchaseJan 17, 2025
Announcement on the Progress of Shareholding Increase by Persons Acting in Concert of Actual ControllersJan 14, 2025

Later from Qingdao Haier Biomedical

Announcement on the Result of Shareholding Increase by Persons Acting in Concert of Actual ControllersApr 11, 2025
Announcement on Attending the Annual Collective Performance Briefing for Medical Device Industry on STAR Market 2024Apr 17, 2025
Report for Q1 2025Apr 30, 2025
Announcement on Attending 2025 Online Collective Reception Day for Investors of Listed Companies in Qingdao JurisdictionMay 1, 2025
Announcement on Implementation of Dividend Distribution for 2024May 30, 2025

All Qingdao Haier Biomedical news releases

Follow Qingdao Haier Biomedical into a list and get an email when it puts out news.

Follow Qingdao Haier Biomedical